- N-PYRIDIN-3-YL OR N-PYRAZIN-2-YL CARBOXAMIDES
-
The present invention relates to compounds of formula I, wherein A, R1 to R7 are defined in the description, and to pharmaceutically acceptable salts thereof. The present invention also relates to the manufacture of such compounds or
- -
-
Page/Page column 30
(2012/04/23)
-
- N-PYRIDIN-3-YL OR N-PYRAZIN-2-YL CARBOXAMIDES
-
The present invention relates to compounds of the formula I wherein A, R1 to R7 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and thei
- -
-
Page/Page column 68
(2012/05/04)
-
- HETEROARYLMETHYL AMIDES
-
The present invention relates to compounds of the formula wherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
- -
-
Page/Page column 26
(2012/03/27)
-
- HETEROARYLMETHYL AMIDES
-
The present invention relates to compounds of the formula I wherein A1, A2, A3 and R1 to R8 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
- -
-
Page/Page column 55
(2012/03/27)
-
- OXIME COMPOUNDS AS HDL-CHOLESTEROL RAISING AGENTS
-
The present invention relates to compounds of the formula (I) wherein A1 to A3 and R1 to R9 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
- -
-
Page/Page column 67-68
(2012/06/30)
-
- OXIME COMPOUNDS
-
The present invention relates to compounds of the formula wherein A1 to A3 and R1 to R9 are defined in the description, and to pharmaceutically acceptable salts thereof, their manufacture, pharmaceutical compositions containing them and their use as medicaments for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as particularly dyslipidemia, atherosclerosis and cardiovascular diseases.
- -
-
Page/Page column 32
(2012/06/30)
-